⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
COGT News
Cogent Biosciences, Inc. Common Stock
Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)
globenewswire.com
COGT
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results
globenewswire.com
COGT
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting
globenewswire.com
COGT
Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
globenewswire.com
COGT
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
COGT